Cargando…

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

Detalles Bibliográficos
Autores principales:	Casadei-Gardini, A, Montagnani, F, Casadei, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599855/ https://www.ncbi.nlm.nih.gov/pubmed/31417303 http://dx.doi.org/10.2147/CMAR.S215110

Ejemplares similares

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Long-Term Outcomes of Chemoradiation for Anal Cancer Patients
por: Kim, Hun Jin, et al.
Publicado: (2013)

Corrigendum to “A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis”
por: Kongnyuy, Michael, et al.
Publicado: (2016)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

Corrigendum to “Investigation of borneols sold in Taiwan by chiral gas chromatography” [J Food Drug Anal 26 (2018) 348–352]
por: Ho, Tsung-Jung, et al.
Publicado: (2019)

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2004)

Corrigendum to “Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients” [J Food Drug Anal 24 (2016) 876–880]
por: Lin, Cheng-Jui, et al.
Publicado: (2017)

Corrigendum to “Toward smart diagnosis of pandemic infectious diseases using wastewater-based epidemiology” [Trac. Trends Anal. Chem. 153 (2022) 116635]
por: Mahmoudi, Tohid, et al.
Publicado: (2022)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer
por: Pittaka, Maria, et al.
Publicado: (2017)

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)
por: Capelli, Laura, et al.
Publicado: (2016)

Corrigendum to “Flavone glycosides from commercially available Lophatheri Herba and their chromatographic fingerprinting and quantitation” [J Food Drug Anal 23 (2015) 821–827]
por: Fan, Jyun-Siang, et al.
Publicado: (2016)

Corrigendum to “Hydrolysis of isoflavone in black soy milk using cellulose bead as enzyme immobilizer” [J Food Drug Anal 24 (2016) 788–795]
por: Chen, Kuan-I, et al.
Publicado: (2017)

The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
por: Rimini, Margherita, et al.
Publicado: (2021)

Corrigendum to “Evaluation of a health-promoting school program to enhance correct medication use in Taiwan” [J Food Drug Anal 22 (2014) 271–278]
por: Chi, Hsueh-Yun, et al.
Publicado: (2016)

Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2021)

A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer
por: Savoie, Marissa B., et al.
Publicado: (2019)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Corrigendum to “Characterizing diversity based on nutritional and bioactive compositions of yam germplasm (Dioscorea spp.) commonly cultivated in China” [J Food Drug Anal 24 (2016) 367–375]
por: Wu, Zhi-Gang, et al.
Publicado: (2016)

The Role of Inflammation in Anal Cancer
por: Selimagic, Amir, et al.
Publicado: (2022)

Cryotherapy for low rectal and anal cancer: recommendation and indications
por: Jiang, Xuejun, et al.
Publicado: (2023)

Whither Anal Cancer?
por: Heriot, Alexander G.
Publicado: (2020)

Immunotherapy in Anal Cancer
por: Dhawan, Natasha, et al.
Publicado: (2023)

A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT)
por: Stieler, Florian, et al.
Publicado: (2009)

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
por: Casadei Gardini, Andrea, et al.
Publicado: (2014)

Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
por: Afaq, A, et al.
Publicado: (2015)

Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database
por: Bian, Shelly X., et al.
Publicado: (2020)

Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study
por: Chu, William, et al.
Publicado: (2023)

Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]
por: Dwi Rizkita, Leonny, et al.
Publicado: (2022)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Publicado: (2022)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014)

CORRIGENDUM: Correction of 4th author's name: The Krüppel-like factor (KLF5) as a predictive biomarker in preoperative chemoradiation therapy for rectal cancer
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Corrigendum to “High-throughput liquid chromatography tandem mass spectrometry method for simultaneous determination of fampridine, paroxetine, and quinidine in rat plasma: Application to in vivo perfusion study” [J Food Drug Anal 24 (2016) 866–875]
por: Achanti, Suneetha, et al.
Publicado: (2017)

Anales
por: Tácito, Cornelio
Publicado: (1975)

Anales
por: Tácito, Cornelio
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_vhlqb170uav6vqroi831pqj07u